Circulating tumour cells: the evolving concept and the inadequacy of their enrichment by EpCAM-based methodology for basic and clinical cancer research.

No abstract is available for this paper.

• Publication year

  2014

• Venue

  Annals of Oncology

• Publication date

  2014-08-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1093/annonc/mdu018PMID 24651410
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Enrichment of cancer cells from whole blood using a microfabricated porous filter.

  2013cited by this paper
• Presence of EpCAM‐positive circulating tumor cells as biomarker for systemic disease strongly correlates to survival in patients with hepatocellular carcinoma

  2013cited by this paper
• Circulating Breast Tumor Cells Exhibit Dynamic Changes in Epithelial and Mesenchymal Composition

  2013influential reference
• Epithelial cell adhesion molecule-positive circulating tumor cells as predictive biomarker in patients with prostate cancer.

  2013cited by this paper
• Negative enrichment of circulating tumor cells using a geometrically activated surface interaction chip.

  2013cited by this paper
• Microfluidic flow fractionation device for label-free isolation of circulating tumor cells (CTCs) from breast cancer patients.

  2013cited by this paper
• Circulating tumor cells: a review of present methods and the need to identify heterogeneous phenotypes.

  2013cited by this paper
• Circulating tumor cells and circulating tumor DNA.

  2012cited by this paper
• Epithelial-Mesenchymal Transition: A Hallmark in Metastasis Formation Linking Circulating Tumor Cells and Cancer Stem Cells

  2012cited by this paper
• Expression of stem cell and epithelial-mesenchymal transition markers in primary breast cancer patients with circulating tumor cells

  2012influential reference
• Analysis of Circulating Tumor Cells in Patients with Non-small Cell Lung Cancer Using Epithelial Marker-Dependent and -Independent Approaches

  2012cited by this paper
• Circulating tumor cells in small-cell lung cancer: a predictive and prognostic factor.

  2012cited by this paper
• Mesenchymal characterization: alternative to simple CTC detection in two clinical trials.

  2012cited by this paper
• Collective migration: spatial tension relief.

  2012cited by this paper
• Epithelial–Mesenchymal Transition and Stem Cell Markers in Patients with HER2-Positive Metastatic Breast Cancer

  2012cited by this paper
• Analysis of the specificity and selectivity of anti-EpCAM antibodies in breast cancer cell lines.

  2012cited by this paper
• Alternative origins of stroma in normal organs and disease.

  2012cited by this paper
• A novel method for the in vivo isolation of circulating tumor cells from peripheral blood of cancer patients using a functionalized and structured medical wire

  2012cited by this paper
• Prognostic Impact of Circulating Tumor Cells in Patients with Small Cell Lung Cancer

  2012cited by this paper
• A dynamic in vivo model of epithelial-to-mesenchymal transitions in circulating tumor cells and metastases of breast cancer

  2012cited by this paper
• Challenges in the Enumeration and Phenotyping of CTC

  2012cited by this paper
• Prognostic impact of circulating tumor cells assessed with the CellSearch System™ and AdnaTest Breast™ in metastatic breast cancer patients: the DETECT study

  2012cited by this paper
• Cancer stem cells and metastasis.

  2012cited by this paper
• Detection of circulating tumor cells in advanced head and neck cancer using the cellsearch system

  2012cited by this paper
• Epithelial cell adhesion molecule expression (CD326) in cancer: a short review.

  2012cited by this paper
• Epithelial Mesenchymal Transition: A New Insight into the Detection of Circulating Tumor Cells

  2012cited by this paper
• Multimarker Analysis of Circulating Tumor Cells in Peripheral Blood of Metastatic Breast Cancer Patients: A Step Forward in Personalized Medicine

  2012cited by this paper
• Circulating tumour cells, their role in metastasis and their clinical utility in lung cancer.

  2012cited by this paper
• High independent prognostic and predictive value of circulating tumor cells compared with serum tumor markers in a large prospective trial in first-line chemotherapy for metastatic breast cancer patients.

  2012cited by this paper
• Demasking of epithelial cell adhesion molecule (EpCAM) on circulating epithelial tumor cells by Tween®20 treatment in breast cancer patients

  2012cited by this paper
• Prognostic significance of CTCs and CSCs of tumor drainage vein blood in Dukes' stage B and C colorectal cancer patients

  2012cited by this paper
• Plasticity of disseminating cancer cells in patients with epithelial malignancies

  2012cited by this paper
• The evolving concept of cancer and metastasis stem cells

  2012cited by this paper
• Identification of pancreatic cancer stem cells and selective toxicity of chemotherapeutic agents.

  2012cited by this paper
• Prognostic Value of EMT-Circulating Tumor Cells in Metastatic Breast Cancer Patients Undergoing High-Dose Chemotherapy with Autologous Hematopoietic Stem Cell Transplantation

  2012cited by this paper
• Detection of circulating tumor cells in blood of metastatic breast cancer patients using a combination of cytokeratin and EpCAM antibodies

  2012cited by this paper
• Prognostic Value of Putative Circulating Cancer Stem Cells in Patients Undergoing Hepatic Resection for Colorectal Liver Metastasis

  2012cited by this paper
• Cancer stem cells and EMT in carcinoma

  2012cited by this paper
• Multiparameter Analysis, including EMT Markers, on Negatively Enriched Blood Samples from Patients with Squamous Cell Carcinoma of the Head and Neck

  2012influential reference
• Prognostic value of circulating tumor cells in nonmuscle invasive bladder cancer: a CellSearch analysis.

  2012cited by this paper
• Comparison of assay methods for detection of circulating tumor cells in metastatic breast cancer: AdnaGen AdnaTest BreastCancer Select/Detect™ versus Veridex CellSearch™ system

  2012cited by this paper
• Circulating tumour cells in non-metastatic breast cancer: a prospective study.

  2012cited by this paper
• CD49f-based selection of circulating tumor cells (CTCs) improves detection across breast cancer subtypes.

  2012cited by this paper
• Meta-Analysis of the Prognostic Value of Circulating Tumor Cells in Breast Cancer

  2012cited by this paper
• Mesenchymal and stemness circulating tumor cells in early breast cancer diagnosis

  2012cited by this paper
• EMT and dissemination precede pancreatic tumor formation.

  2012cited by this paper
• Circulating tumour cells escape from EpCAM-based detection due to epithelial-to-mesenchymal transition

  2012cited by this paper
• Circulating Tumor Cells: The Substrate of Personalized Medicine?

  2012cited by this paper
• Single Cell Profiling of Circulating Tumor Cells: Transcriptional Heterogeneity and Diversity from Breast Cancer Cell Lines

  2012cited by this paper
• Molecular Characterization of Circulating Tumor Cells in Human Metastatic Colorectal Cancer

  2012cited by this paper
• Distinct types of tumor-initiating cells form human colon cancer tumors and metastases.

  2011cited by this paper
• The Hippo transducer TAZ confers cancer stem cell-related traits on breast cancer cells.

  2011cited by this paper
• Clinical relevance and biology of circulating tumor cells

  2011cited by this paper
• Disseminated and circulating tumor cells: Role in effective cancer management.

  2011cited by this paper
• A novel platform for detection of CK+ and CK- CTCs.

  2011cited by this paper
• Detection of circulating tumor cells as a prognostic factor in patients undergoing radical surgery for non‐small‐cell lung carcinoma: comparison of the efficacy of the CellSearch Assay™ and the isolation by size of epithelial tumor cell method

  2011cited by this paper
• Angiogenesis , Metastasis , and the Cellular Microenvironment Circulating Tumor Cells from Patients with Advanced Prostate and Breast Cancer Display Both Epithelial and Mesenchymal Markers

  2011influential reference
• High-throughput selection, enumeration, electrokinetic manipulation, and molecular profiling of low-abundance circulating tumor cells using a microfluidic system.

  2011cited by this paper
• Circulating Tumor Cells and EpCAM Expression in Neuroendocrine Tumors

  2011cited by this paper
• Epithelial to mesenchymal transition markers expressed in circulating tumour cells of early and metastatic breast cancer patients

  2011influential reference
• A pilot study to explore circulating tumour cells in pancreatic cancer as a novel biomarker

  2011cited by this paper
• Cancer stem cells in squamous cell carcinoma switch between two distinct phenotypes that are preferentially migratory or proliferative.

  2011cited by this paper
• Circulating tumor cells: not all detected cells are bad and not all bad cells are detected.

  2011cited by this paper
• Detection of EpCAM-Negative and Cytokeratin-Negative Circulating Tumor Cells in Peripheral Blood

  2011cited by this paper
• Detection of circulating tumour cells with a hybrid (epithelial/mesenchymal) phenotype in patients with metastatic non-small cell lung cancer

  2011cited by this paper
• Evaluation and prognostic significance of circulating tumor cells in patients with non-small-cell lung cancer.

  2011cited by this paper
• Detection of circulating tumor cells in breast cancer may improve through enrichment with anti-CD146

  2011cited by this paper
• Circulating tumor cells: approaches to isolation and characterization

  2011cited by this paper
• Expression of epithelial–mesenchymal transition‐inducing transcription factors in primary breast cancer: The effect of neoadjuvant therapy

  2011cited by this paper
• Circulating tumor cells: the Grand Challenge.

  2011cited by this paper
• A high-performance microsystem for isolating circulating tumor cells.

  2011cited by this paper
• The U.S. plays catch up.

  2011cited by this paper
• Circulating tumor cells (CTCs) in metastatic breast cancer (MBC): prognosis, drug resistance and phenotypic characterization.

  2011cited by this paper
• Circulating tumor cells in breast cancer: A tool whose time has come of age

  2011cited by this paper
• Circulating tumor cells predict progression free survival and overall survival in patients with relapsed/recurrent advanced ovarian cancer.

  2011cited by this paper
• Circulating tumour cells lacking cytokeratin in breast cancer: the importance of being mesenchymal

  2011cited by this paper
• Nano "fly paper" technology for the capture of circulating tumor cells.

  2011cited by this paper
• Circulating tumor cells as a window on metastasis biology in lung cancer.

  2011cited by this paper
• Cancer cells in epithelial-to-mesenchymal transition and tumor-propagating–cancer stem cells: distinct, overlapping or same populations

  2011cited by this paper
• Direct signaling between platelets and cancer cells induces an epithelial-mesenchymal-like transition and promotes metastasis.

  2011cited by this paper
• Comparison of three distinct methods for the detection of circulating tumor cells in colorectal cancer patients.

  2011cited by this paper
• Circulating tumor cells as prognostic and predictive markers in metastatic breast cancer patients receiving first-line systemic treatment

  2011cited by this paper
• A Perspective on Cancer Cell Metastasis

  2011cited by this paper
• Modeling and imaging 3-dimensional collective cell invasion.

  2011cited by this paper
• Circulating tumor cells and "suspicious objects" evaluated through CellSearch® in metastatic renal cell carcinoma.

  2011cited by this paper
• Elucidating an uncommon disease: inflammatory breast cancer.

  2011cited by this paper
• Disseminated and circulating tumor cells for monitoring chemotherapy in urological tumors.

  2011cited by this paper
• Hallmarks of cancer: the next generation.

  2011cited by this paper
• Clinical significance of circulating tumor cells, including cancer stem-like cells, in peripheral blood for recurrence and prognosis in patients with Dukes' stage B and C colorectal cancer.

  2011cited by this paper
• Circulating tumor cells in breast cancer: detection systems, molecular characterization, and future challenges.

  2011cited by this paper
• The ins and outs of the epithelial to mesenchymal transition in health and disease.

  2011cited by this paper
• Detection of EpCAM positive and negative circulating tumor cells in metastatic breast cancer patients

  2011cited by this paper
• Epithelial-mesenchymal transition and stemness features in circulating tumor cells from breast cancer patients

  2011influential reference
• Circulating tumor cell isolation and diagnostics: toward routine clinical use.

  2011cited by this paper
• M30 Neoepitope Expression in Epithelial Cancer: Quantification of Apoptosis in Circulating Tumor Cells by CellSearch Analysis

  2010cited by this paper
• Molecular Biomarker Analyses Using Circulating Tumor Cells

  2010cited by this paper
• Circulating tumour cells in cancer patients: challenges and perspectives.

  2010cited by this paper
• Circulating tumour cells in clinical practice: Methods of detection and possible characterization.

  2010cited by this paper
• Versatile label free biochip for the detection of circulating tumor cells from peripheral blood in cancer patients.

  2010cited by this paper
• Expression of the stem cell marker nestin in peripheral blood of patients with melanoma

  2010cited by this paper

• Surface Marker Identification to Capture Live Circulating Tumor Cells in Metastatic Triple-Negative Breast Cancer

  2026cites this paper
• Neoadjuvant therapy and translational biomarkers for metastatic risk in early breast cancer.

  2026cites this paper
• A Phase II Pilot Study of Anti‐PD‐L1, Durvalumab, and a PARP Inhibitor, Olaparib in Patients With Metastatic Triple‐Negative Breast Cancer With or Without Germline BRCA Mutation

  2025cites this paper
• AXL signaling in cancer: from molecular insights to targeted therapies

  2025cites this paper
• Liquid biopsy for the management of gastrointestinal cancers.

  2025cites this paper
• Circulating tumor cells in liquid biopsy: progress and challenges in detection and quantification

  2025cites this paper
• Photoelectrochemical-fluorescence dual-mode microchip for in situ capture and phenotypic analysis of tumor cells

  2025cites this paper
• A Device for the Removal of Peripheral Blood Circulating Tumor Cells and Inhibiting Their Biodistribution

  2025cites this paper
• EpCAM Signaling in Oral Cancer Stem Cells: Implications for Metastasis, Tumorigenicity, and Therapeutic Strategies

  2025cites this paper
• Associations of blood RNA biomarkers and circulating tumour cells in patients with previously untreated metastatic colorectal cancer

  2025cites this paper
• Development of new techniques and clinical applications of liquid biopsy in lung cancer management.

  2024cites this paper
• Microfluidic-SERS Technologies for CTC: A Perspective on Clinical Translation.

  2024cites this paper
• Clinical Application of Different Liquid Biopsy Components in Hepatocellular Carcinoma

  2024cites this paper
• Review on effects and mechanisms of plant-derived natural products against breast cancer bone metastasis

  2024cites this paper
• Presence of CD44v9-Expressing Cancer Stem Cells in Circulating Tumor Cells and Effects of Carcinoembryonic Antigen Levels on the Prognosis of Colorectal Cancer

  2024cites this paper
• The CHK1 inhibitor prexasertib in BRCA wild-type platinum-resistant recurrent high-grade serous ovarian carcinoma: a phase 2 trial

  2024cites this paper
• Label-free detection and simultaneous viability determination of CTCs by lens-free imaging cytometry

  2024cites this paper
• Image-based machine learning quantitative evaluation of bead-cell binding interaction

  2024cites this paper
• Protocol of the HISTOTHERM study: assessing the response to hyperthermia and hypofractionated radiotherapy in recurrent breast cancer

  2023cites this paper
• Magnetic Bead Conjugated Lung Tumor Cell Binding Efficiency Assessment Based on Deep-Learning Approach

  2023cites this paper
• Circulating Tumor Cells Adhesion: Application in Biosensors

  2023cites this paper
• Automated Capture and Analysis of Circulating Tumor Cells in Pediatric, Adolescent and Young Adult Patients with Central Nervous System Tumors

  2023cites this paper
• Analysis of the incidence of breast cancer in the Krasnoyarsk Territory

  2023cites this paper
• Cell State and Cell Type: Deconvoluting Circulating Tumor Cell Populations in Liquid Biopsies by Multi-Omics

  2023cites this paper
• Deciphering the Biology of Circulating Tumor Cells through Single-Cell RNA Sequencing: Implications for Precision Medicine in Cancer

  2023cites this paper
• An Overview of Circulating Biomarkers in Neuroendocrine Neoplasms: A Clinical Guide

  2023cites this paper
• A comparative study on ctDNA and tumor DNA mutations in lung cancer and benign cases with a high number of CTCs and CTECs

  2023cites this paper
• Quantification of capture efficiency, purity, and single-cell isolation in the recovery of circulating melanoma cells from peripheral blood by dielectrophoresis

  2023cites this paper
• Analysis of the incidence of breast cancer in the Krasnoyarsk Territory

  2023cites this paper
• Circulating tumor cells as a predictor and prognostic tool for metastatic clear cell renal carcinoma: An immunocytochemistry and genomic analysis.

  2023cites this paper
• Intelligent recognition of CTCs from gallbladder cancer by ultrasensitive electrochemical cytosensor and diagnosis of chemotherapeutic resistance.

  2023cites this paper
• Hsp70—A Universal Biomarker for Predicting Therapeutic Failure in Human Female Cancers and a Target for CTC Isolation in Advanced Cancers

  2023cites this paper
• Epithelial-to-Mesenchymal Transition Gene Signature in Circulating Melanoma Cells: Biological and Clinical Relevance

  2023cites this paper
• DNA nanotechnology in tumor liquid biopsy: Enrichment and determination of circulating biomarkers

  2023cites this paper
• New Challenges in Evaluating Outcomes after Immunotherapy in Recurrent and/or Metastatic Head and Neck Squamous Cell Carcinoma

  2022cites this paper
• Chemokines in Triple-Negative Breast Cancer Heterogeneity: New Challenges for Clinical Implications.

  2022cites this paper
• Methods for the Detection of Circulating Biomarkers in Cancer Patients.

  2022cites this paper
• Circulating tumor cells isolated from colorectal cancer patients can form spheroids spontaneously: a small study in Ciptomangunkusumo Hospital, Indonesia [version 1; peer review: awaiting peer review]

  2022cites this paper
• Circulating tumor cells isolated from colorectal cancer patients can form spheroids spontaneously: a small study in Ciptomangunkusumo Hospital, Indonesia

  2022cites this paper
• Identification of Key Genes and Pathways Involved in Circulating Tumor Cells in Colorectal Cancer

  2022cites this paper
• Circulating tumor cells in oncology

  2022cites this paper
• Cancer Stem Cells and Circulatory Tumor Cells Promote Breast Cancer Metastasis.

  2022cites this paper
• Circulating tumor cell isolation for cancer diagnosis and prognosis

  2022cites this paper
• Basic Principles and Recent Advances in Magnetic Cell Separation

  2022cites this paper
• Bioinspired nano-plate-coral platform enabled efficient detection of circulating tumor cells via the synergistic capture of multivalent aptamer and tumor cell membrane.

  2022cites this paper
• Geometric tumor embolic budding characterizes inflammatory breast cancer

  2022cites this paper
• Liquid biopsy and preclinical tools for advancing diagnosis and treatment of patients with pancreatic neuroendocrine neoplasms.

  2022cites this paper
• Pro-metastatic and mesenchymal gene expression signatures characterize circulating tumor cells of neuroblastoma patients with bone marrow metastases and relapse

  2022cites this paper
• Characterizing the epithelial–mesenchymal transition status of circulating tumor cells in head and neck squamous cell carcinoma

  2022influential citation
• Enrichment of Cancer Cells Based on Antibody-Free Selective Cell Adhesion.

  2022cites this paper
• Cancer metastasis chemoprevention prevents circulating tumour cells from germination

  2022cites this paper
• Circulating Tumor Cell Identification Based on Deep Learning

  2022cites this paper
• Role of Epithelial-to-Mesenchymal Transition for the Generation of Circulating Tumors Cells and Cancer Cell Dissemination

  2022cites this paper
• Unbiased Enrichment of Circulating Tumor Cells Via DNAzyme-Catalyzed Proximal Protein Biotinylation.

  2022cites this paper
• The Mechanical Fingerprint of Circulating Tumor Cells (CTCs) in Breast Cancer Patients

  2021influential citation
• PD-L1 Expression in Circulating Tumor Cells as a Promising Prognostic Biomarker in Advanced Non-small-cell Lung Cancer Treated with Immune Checkpoint Inhibitors.

  2021cites this paper
• Enrichment and detection method for the prognostic value of circulating tumor cells in ovarian cancer: A meta-analysis.

  2021cites this paper
• Diagnostic Value of the Circulating Tumor Cells and Circulating Tumor-Derived Endothelial Cells Detection for Non-Small Cell Lung Cancer

  2021cites this paper
• Clinical Significance of Circulating Tumor Cells in Unresectable Pancreatic Ductal Adenocarcinomas

  2021cites this paper
• Influence of adjuvant radiotherapy on circulating epithelial tumor cells and circulating cancer stem cells in primary non-metastatic breast cancer

  2021cites this paper
• Sorting and identification of circulating tumor cells of gliomas with EGFR antibody-modified immunomagnetic microspheres

  2021cites this paper
• Clinical significance of circulating tumor cells after chemotherapy in unresectable pancreatic ductal adenocarcinoma

  2021cites this paper
• Early detection of tumor cells in bone marrow and peripheral blood in a fast-progressing gastric cancer model

  2021cites this paper
• IsoMAG—An Automated System for the Immunomagnetic Isolation of Squamous Cell Carcinoma-Derived Circulating Tumor Cells

  2021cites this paper
• A new insight to deformability correlation of circulating tumor cells with metastatic behavior by application of a new deformability-based microfluidic chip.

  2021cites this paper
• Vimentin-Positive Circulating Tumor Cells as Diagnostic and Prognostic Biomarkers in Patients with Biliary Tract Cancer

  2021cites this paper
• Seeding metastases: The role and clinical utility of circulating tumour cells.

  2021cites this paper
• Detection of circulating rare cells benefitted the diagnosis of malignant solitary pulmonary nodules

  2021cites this paper
• The Hallmarks of Ovarian Cancer: Actionable Genetics, Targetable Pathways, and Predictive Biomarkers

  2021cites this paper
• CD44+ Circulating Tumor Endothelial Cells Indicate Poor Prognosis in Pancreatic Ductal Adenocarcinoma After Radical Surgery: A Pilot Study

  2021cites this paper
• Diagnosis of Non-Small Cell Lung Cancer via Liquid Biopsy Highlighting a Fluorescence-in-situ-Hybridization Circulating Tumor Cell Approach

  2021cites this paper
• CMAR_A_309115 4417..4431

  2021cites this paper
• Biosensors and nanotechnology for cancer diagnosis (lung and bronchus, breast, prostate, and colon): a systematic review

  2021cites this paper
• Gastrointestinal Stromal Tumors (GISTs): Novel Therapeutic Strategies with Immunotherapy and Small Molecules

  2021cites this paper
• Detection of AXL expression in circulating tumor cells of lung cancer patients using an automated microcavity array system

  2020cites this paper
• A New Method for CTC Images Recognition Based on Machine Learning

  2020cites this paper
• Examination of the dielectrophoretic spectra of MCF7 breast cancer cells and leukocytes

  2020cites this paper
• High-throughput dynamical analysis of dielectrophoretic frequency dispersion of single cells based on deflected flow streamlines

  2020cites this paper
• Genome-wide copy number analysis of circulating tumor cells in breast cancer patients with liver metastasis

  2020cites this paper
• ALICE: a hybrid AI paradigm with enhanced connectivity and cybersecurity for a serendipitous encounter with circulating hybrid cells

  2020cites this paper
• In Vivo Lymphatic Circulating Tumor Cells and Progression of Metastatic Disease

  2020cites this paper
• Effect of cell-nanostructured substrate interactions on the capture efficiency of HeLa cells

  2020cites this paper
• Detection of Circulating Tumor Cells and Cell Free DNA in Cancer Management

  2020cites this paper
• EMT-Associated Heterogeneity in Circulating Tumor Cells: Sticky Friends on the Road to Metastasis

  2020cites this paper
• Tumor Hypoxia and Circulating Tumor Cells

  2020cites this paper
• Liquid Biopsy Analysis of Circulating Tumor Biomarkers in Lung Cancer

  2020cites this paper
• Methodology for the Isolation and Analysis of CTCs.

  2020cites this paper
• Inflammation-Based Scores Increase the Prognostic Value of Circulating Tumor Cells in Primary Breast Cancer

  2020cites this paper
• Early detection of biomarkers for circulating tumor cells in Bone marrow and Peripheral blood in a fast-progressing gastric cancer model

  2020cites this paper
• Liquid Biopsy Serial Monitoring of Treatment Responses and Relapse in Advanced Esophageal Squamous Cell Carcinoma

  2020cites this paper
• Circulating tumor markers: harmonizing the yin and yang of CTCs and ctDNA for precision medicine

  2019cites this paper
• Circulating Tumor Cells and Their Clinical Significance in Gastric Cancer

  2019cites this paper
• Baseline circulating stem-like cells predict survival in patients with metastatic breast Cancer

  2019cites this paper
• Evaluation of metastatic potential of circulating tumor cells using quantitative phase imaging (QPI)

  2019cites this paper
• High sensitive detection of circulating tumor cell by multimarker lipid magnetic nanoparticles and clinical verifications

  2019cites this paper
• Clinical significance of circulating tumor cells and tumor markers in the diagnosis of lung cancer

  2019cites this paper
• Advanced liquid biopsy technologies for circulating biomarker detection.

  2019cites this paper
• Detection of human mammaglobin mRNA in breast cancer cells among Vietnamese women

  2019cites this paper
• Developing a blood-based gene mutation assay as a novel biomarker for oesophageal adenocarcinoma

  2019cites this paper
• Nanomedical detection and downstream analysis of circulating tumor cells in head and neck patients

  2019cites this paper